GRAY MICHAEL

Chief Financial Officer at Mellanox Technologies, Ltd. · on record since Feb 7, 2007
CFO and COO at Upstream Bio, Inc. · on record since Oct 10, 2024
CFO, Sr. VP Finance & Admin. at SANDISK CORP · on record since Jul 24, 2003
Chief Financial Officer at CURIS INC · on record since Dec 15, 2003
Director at ACTELIS NETWORKS INC · on record since Nov 15, 2017
President, CEO and CFO at ACTELIS NETWORKS INC · on record since Nov 28, 2018
Director at POINT Biopharma Global Inc. · on record since Jul 7, 2020
CFO & COO at Enliven Therapeutics, Inc. · on record since Mar 11, 2020

Insider trading activity of GRAY MICHAEL

Transactions on record: 387; since Jul 31, 2003

Open-market buys: 1; $28.6K

Open-market sells: 218; $9M

Companies traded: 6; last filing Sep 17, 2026

Figures computed from official regulatory filings — .

Companies where GRAY MICHAEL has traded

Upstream Bio, Inc.6 tx · $17.8K · Sep 17, 2026
Enliven Therapeutics, Inc.8 tx · $97.5K · Feb 22, 2023
ACTELIS NETWORKS INC2 tx · Nov 28, 2018
CURIS INC78 tx · $2.9M · May 28, 2015
Mellanox Technologies, Ltd.272 tx · $8.5M · Nov 5, 2012
SANDISK CORP21 tx · $2.5M · May 28, 2004

Track record of GRAY MICHAEL

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of GRAY MICHAEL

Co-insiders of GRAY MICHAEL

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Upstream Bio, Inc.Listing on record	Sep 17, 2026	Sell	-853	5.49 USD	$4.7K		SEC
Upstream Bio, Inc.Listing on record	Jun 17, 2026	Sell	-853	6.10 USD	$5.2K		SEC
Upstream Bio, Inc.Listing on record	Mar 17, 2026	Sell	-852	9.29 USD	$7.9K		SEC
Upstream Bio, Inc.Listing on record	Jan 6, 2026	AwardD (derivative)	91,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Upstream Bio, Inc.Listing on record	Jan 6, 2026	Award	30,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Upstream Bio, Inc.Listing on record	Feb 7, 2025	AwardD (derivative)	195,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 22, 2023	Sell	-9,856	4.67 USD	$46K		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 1, 2023	Sell	-3,596	3.92 USD	$14.1K		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 1, 2022	Award	39,350	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 1, 2022	AwardD (derivative)	39,350	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Jan 28, 2021	AwardD (derivative)	60,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Dec 15, 2020	Sell	-1,250	25.00 USD	$31.3K		SEC
Enliven Therapeutics, Inc.Listing on record	Dec 15, 2020	Exercise	1,250	4.92 USD	$6.2K		SEC
Enliven Therapeutics, Inc.Listing on record	Dec 15, 2020	ExerciseD (derivative)	-1,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ACTELIS NETWORKS INCListing on record	Nov 28, 2018	Award	250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ACTELIS NETWORKS INCListing on record	Mar 9, 2018	AwardD (derivative)	110,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CURIS INCListing on record	May 28, 2015	AwardD (derivative)	80,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CURIS INCListing on record	Jan 28, 2015	AwardD (derivative)	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CURIS INCListing on record	Feb 20, 2014	AwardD (derivative)	120,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CURIS INCListing on record	Feb 20, 2014	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CURIS INCListing on record	Nov 12, 2013	Buy	10,000	2.86 USD	$28.6K	conv 72ClusterFirst in 12mo	SEC
CURIS INCListing on record	May 23, 2013	Gift	-6,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CURIS INCListing on record	May 7, 2013	Exercise	242	2.43 USD	$588.1		SEC
CURIS INCListing on record	May 7, 2013	Exercise	49,758	2.43 USD	$120.9K	Unusual size	SEC
CURIS INCListing on record	May 7, 2013	ExerciseD (derivative)	-49,758	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Upstream Bio, Inc.Listing on record	Sep 17, 2026	Sell	-853	5.49 USD	$4.7K		SEC
Upstream Bio, Inc.Listing on record	Jun 17, 2026	Sell	-853	6.10 USD	$5.2K		SEC
Upstream Bio, Inc.Listing on record	Mar 17, 2026	Sell	-852	9.29 USD	$7.9K		SEC
Upstream Bio, Inc.Listing on record	Jan 6, 2026	AwardD (derivative)	91,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Upstream Bio, Inc.Listing on record	Jan 6, 2026	Award	30,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Upstream Bio, Inc.Listing on record	Feb 7, 2025	AwardD (derivative)	195,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 22, 2023	Sell	-9,856	4.67 USD	$46K		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 1, 2023	Sell	-3,596	3.92 USD	$14.1K		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 1, 2022	Award	39,350	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 1, 2022	AwardD (derivative)	39,350	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Jan 28, 2021	AwardD (derivative)	60,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Dec 15, 2020	Sell	-1,250	25.00 USD	$31.3K		SEC
Enliven Therapeutics, Inc.Listing on record	Dec 15, 2020	Exercise	1,250	4.92 USD	$6.2K		SEC
Enliven Therapeutics, Inc.Listing on record	Dec 15, 2020	ExerciseD (derivative)	-1,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ACTELIS NETWORKS INCListing on record	Nov 28, 2018	Award	250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ACTELIS NETWORKS INCListing on record	Mar 9, 2018	AwardD (derivative)	110,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CURIS INCListing on record	May 28, 2015	AwardD (derivative)	80,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CURIS INCListing on record	Jan 28, 2015	AwardD (derivative)	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CURIS INCListing on record	Feb 20, 2014	AwardD (derivative)	120,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CURIS INCListing on record	Feb 20, 2014	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CURIS INCListing on record	Nov 12, 2013	Buy	10,000	2.86 USD	$28.6K	conv 72ClusterFirst in 12mo	SEC
CURIS INCListing on record	May 23, 2013	Gift	-6,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CURIS INCListing on record	May 7, 2013	Exercise	242	2.43 USD	$588.1		SEC
CURIS INCListing on record	May 7, 2013	Exercise	49,758	2.43 USD	$120.9K	Unusual size	SEC
CURIS INCListing on record	May 7, 2013	ExerciseD (derivative)	-49,758	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC